To investigate the influence of different backgrounds of double-phase technetium-
99
m methoxyisobutylisonitrile (
99
mTc-MIBI) SPECT on predicting the efficacy of neoadjuvant chemotherapy for nasopharyngeal carcinoma.
Methods:
Thirty-two patients of nasopharyngeal carcinoma proven by pathology were chosen. All patients adopted double-phase
99
mTc-MIBI SPECT before chemotherapy. The regions of interest (ROIs) drawn in the transverse slices with obvious lesions were copied to cerebrum
trapezius and lung. The relationships between efficacy of neoadjuvant chemotherapy and the early uptake ratio
late uptake ratio and washout rate of
99
mTc-MIBI were evaluated. The receiver operating characteristic (ROC) curve was made according to MRI results to determine the cutoff value of diagnosis.
Results:
The high response group had higher early uptake ratio and late uptake ratio than the low response group. The early uptake ratio of
99
mTc-MIBI was best when cerebrum was set as background. The area under ROC curve (ROC-AUC) was 0.943 (
SE
=0.042; 95%
CI
=0.860-1.026;
P
=0.002). The sensitivity and specificity were 91.4% and 80.0%
respectively. The late uptake ratio of
99
mTc-MIBI was best when cerebrum was set as background
with AUC of 0.929 (
SE
=0.050; 95%
CI
=0.831-1.027;
P
=0.02)
sensitivity of 85.7%
and specificity of 77.3%.
Conclusion:
When cerebrum is chosen as background
the uptake ratio of
99
mTc-MIBI on predicting the efficacy of chemotherapy for nasopharyngeal carcinoma is a perfect index.